0% found this document useful (0 votes)
117 views

101 Test Aarogya 2.0:: Mrs - Phulwanti Kaur

Mrs. Phulwanti Kaur, a 68-year-old female, had several abnormal results on her lipid profile and liver/kidney function tests. Her total cholesterol, HDL cholesterol, and albumin/globulin ratio were slightly high. Her direct bilirubin, blood urea, serum creatinine, urea/creatinine ratio, and BUN/creatinine ratio were high. These results suggest issues with her liver and kidney function that require further monitoring and testing.

Uploaded by

Naunidh Singh
Copyright
© © All Rights Reserved
We take content rights seriously. If you suspect this is your content, claim it here.
Available Formats
Download as PDF, TXT or read online on Scribd
0% found this document useful (0 votes)
117 views

101 Test Aarogya 2.0:: Mrs - Phulwanti Kaur

Mrs. Phulwanti Kaur, a 68-year-old female, had several abnormal results on her lipid profile and liver/kidney function tests. Her total cholesterol, HDL cholesterol, and albumin/globulin ratio were slightly high. Her direct bilirubin, blood urea, serum creatinine, urea/creatinine ratio, and BUN/creatinine ratio were high. These results suggest issues with her liver and kidney function that require further monitoring and testing.

Uploaded by

Naunidh Singh
Copyright
© © All Rights Reserved
We take content rights seriously. If you suspect this is your content, claim it here.
Available Formats
Download as PDF, TXT or read online on Scribd
You are on page 1/ 13

Patient Name : Mrs.

PHULWANTI KAUR
Age/Sex : 68 YRS/F Lab Id. : 012009180092
Refered By : Self Sample Collection On : 18/Sep/2020
Collected By : UMESH KAMAL Sample Lab Rec.On : 18/Sep/2020 05:55 PM
Collection Mode : HOME COLLECTION Reporting On : 18/Sep/2020 07:15 PM
BarCode : 10172896

Test Name Result Biological Ref. Int. Unit

101 TEST AAROGYA 2.0


Lipid Profile (Heart Risk Profile),Serum
TOTAL CHOLESTEROL SERUM 142 130-200 mg/dl
(Method : CHOD-PAP)
The purpose of this test is to check/monitor blood cholesterol level. Serum cholesterol is used as an indicator of
atherosclerosis, coronary artery disease and is an important screening test for heart disease.
Condition associated with increased cholesterol levels : Familial (hereditary) tendency, abnormal dietary intake,
alcoholism, hypothyroidism, Acute MI, nephrotic syndrome, pancreaectomy, billiary obstruction, pregnancy (third
trimester), dru influence such as aspirin, corticosteroids, steroids, oral contraceptives, vitamin A & D, etc
Condition associated with decreased cholesterol levels: Hypo-alpha lipoproteinemia, Hyperthyroidism, Malabsorption
syndrome, starvation, chronic anemia etc
People with increased cholesterol levels are advised to undergo: Lipid Profile and Apolipoprotein A & B at regular
intervals.
TRIGLYCERIDES SERUM 48.3 35 - 170 mg/dl
(Method : GPO )
Triglycerides are blood lipids formed by esterification of glycerol and three fatty acids and are carried by the
serum lipoproteins. The intestine processes the triglycerides from dietary fatty acid and they are transported in
the blood stream as chylomicrones. A function of triglycerides is to provide energy to heart and skeletal muscles.
Triglycerides are major contributor to arterial diseases. As the concentration of triglycerides increases, so will
the VLDL increases. A peak concentration of chylomicron associated triglycerides occurs within 3-6 hrs after
ingestion of fat rich meal. Alcohol intake also causes transient increase of serum TG level. If TG is more than
400 mg/dL, VLDL cannot be calculated.

HIGH DENSITY LIPOPROTEIN CHOLESTEROL 37 42 - 80 mg/dl


(Method : HDL DIRECT)

VERY LOW DENSITY LIPOPROTEIN VLDL 9.66 7 - 34 mg/dl


(Method : Calculated)

LOW DENSITY LIPOPROTEIN 95.34 63 - 129 mg/dl


(Method : Calculated)

Page 1 of 13
Patient Name : Mrs.PHULWANTI KAUR
Age/Sex : 68 YRS/F Lab Id. : 012009180092
Refered By : Self Sample Collection On : 18/Sep/2020
Collected By : UMESH KAMAL Sample Lab Rec.On : 18/Sep/2020 05:55 PM
Collection Mode : HOME COLLECTION Reporting On : 18/Sep/2020 07:15 PM
BarCode : 10172896

Test Name Result Biological Ref. Int. Unit


TOTAL CHOLESTEROL / HDL CHOLESTEROL 3.84 0.1 - 4.0 Ratio
(Method : Calculated)

LDL / HDL CHOLESTEROL RATIO * 2.58 1.5 - 3.5 Ratio


(Method : Calculated)

NON- HDL CHOLESTEROL * 105 < 160 mg/dl


(Method : Calculated)

TOTAL LIPID * 322.64L 400 - 1000 mg/dl


(Method : Calculated)

LIVER FUNCTION TEST,SERUM


BILIRUBIN TOTAL 1.07 0.1-1.20 mg/dL
(Method : DIAZO)

BILIRUBIN DIRECT 0.58H 0.0 - 0.20 mg/dl


(Method : DIAZO)

BILIRUBIN INDIRECT 0.49 0. 00 - 1.00 mg/dl


(Method : Calculated)

PROTEIN TOTAL SERUM 6.5 6.4-8.3 gm/dL


(Method : Biuret End Point)

ALBUMIN SERUM 3.40 3.2-4.6 g/dL


(Method : BCG )

GLOBULIN SERUM 3.10 2.0-3.5 mg/dl


(Method : Calculated)

ALBUMIN / GLOBULIN RATIO 1.10L 1.2 - 2.5 Ratio


(Method : Calculated)

SGOT / AST 28.7 0 - 31 U/l


(Method : IFCC Method Kinetic )

SGPT / ALT 26.0 0 - 45 U/L


(Method : IFCC Method Kinetic )

SGOT/SGPT Ratio 1.10

Page 2 of 13
Patient Name : Mrs.PHULWANTI KAUR
Age/Sex : 68 YRS/F Lab Id. : 012009180092
Refered By : Self Sample Collection On : 18/Sep/2020
Collected By : UMESH KAMAL Sample Lab Rec.On : 18/Sep/2020 05:55 PM
Collection Mode : HOME COLLECTION Reporting On : 18/Sep/2020 07:15 PM
BarCode : 10172896

Test Name Result Biological Ref. Int. Unit


ALKALINE PHOSPHATASE (ALP) 102 53-141 U/L
(Method : AMP)

Kidney Function Test (KFT),Serum


BLOOD UREA 64.1H 12-43 mg/dL
(Method : Urease-GLDH)

BLOOD UREA NITROGEN (BUN) * 30H 6 - 21 mg/dl


(Method : Calculated)

SERUM CREATININE 1.34H 0.60-1.20 mg/dL


(Method : Modified Jaffe,s)

Creatinine is a by product of muscle catabolism. It is filtered by kidney and excreted in the urine. if the filtering of the kidney is deficient, creatinine levels in blood are
increased.

Creatine level is used for the assessment of kidney function and to diagnose renal dysfunction. However, more important than absolute creatinine level is the trend of
serum creatinine levels over time. Serum creatine is especially useful in evaluation of glomerular function. BUN (Blood Urea Nitrogen) & Creatine are frequently
compared. If BUN increased and creatinine is normal, dehydration is present; and if both increased, then renal disorder is present.

Conditions associated with increased creatine level : Acute and chronic renal failure, shock (prolonged), systemic lupus erythematosis, cancer, leukemia ,
hypertension, acute myocardial infaction, diabetic nephropathy , diet rich in creatinine (e.g. beef), congenital renal disease etc.

Condition associated with decreased creatine level : Pregnancy, Eclampsia etc.

Opinion & Advice:


People with increased creatine levels are advised to undergo : Kidney Function Test, Urine Examination & USG (Whole abdomen) at regular intervals.
Decreased creatine levels are usually insignificant.
SERUM URIC ACID 5.5 2.6-6.0 mg/dL
(Method : Uricase-POD)

UREA / CREATININE RATIO * 47.83H 23 - 33 Ratio


(Method : Calculated)

BUN / CREATININE RATIO * 22.35H 5.5 - 19.2 Ratio


(Method : Calculated)

Page 3 of 13
Patient Name : Mrs.PHULWANTI KAUR
Age/Sex : 68 YRS/F Lab Id. : 012009180092
Refered By : Self Sample Collection On : 18/Sep/2020
Collected By : UMESH KAMAL Sample Lab Rec.On : 18/Sep/2020 05:55 PM
Collection Mode : HOME COLLECTION Reporting On : 18/Sep/2020 07:15 PM
BarCode : 10172896

Test Name Result Biological Ref. Int. Unit


GFR * 40.6 mL/min/1.73
m2
(Method : Calculated)

Reference Range :-

> = 90 : Normal
60 - 89 : Mild Decrease
45 - 59 : Mild to Moderate Decrease
30 - 44 : Moderate to Severe Decrease
15 - 29 : Severe Decrease

Clinical Significance

The normal serum creatinine reference interval does not necessarily reflect a normal GFR for a patient. Because mild and moderate
kidney injury is poorly inferred from serum creatinine alone. Thus, it is recommended for clinical laboratories to routinely estimate
glomerular filtration rate (eGFR), a “gold standard” measurement for assessment of renal function, and report the value when serum
creatinine is measured for patients 18 and older, when appropriate and feasible. It cannot be measured easily in clinical practice,
instead, GFR is estimated from equations using serum creatinine, age, race and sex. This provides easy to interpret information for
the doctor and patient on the degree of renal impairment since it approximately equates to the percentage of kidney function
remaining. Application of CKD-EPI equation together with the other diagnostic tools in renal medicine will further improve the
detection and management of patients with CKD.

Reference

Levey AS, Stevens LA, Schmid CH, Zhang YL, Castro AF, 3rd, Feldman HI, et al. A new equation to estimate glomerular filtration
rate. Ann Intern Med. 2009;150(9):604-12.

Page 4 of 13
Patient Name : Mrs.PHULWANTI KAUR
Age/Sex : 68 YRS/F Lab Id. : 012009180092
Refered By : Self Sample Collection On : 18/Sep/2020
Collected By : UMESH KAMAL Sample Lab Rec.On : 18/Sep/2020 05:55 PM
Collection Mode : HOME COLLECTION Reporting On : 18/Sep/2020 07:15 PM
BarCode : 10172896

Test Name Result Biological Ref. Int. Unit


INORGANIC PHOSPHORUS 4.12 2.5-4.5 mg/dL
(Method : UV Molybdate)

DIABETES PROFILE
BLOOD SUGAR FASTING,Plasma Floride 124.36H 70 - 110 mg/dl
(Method : GOD-POD)

GLUCOSE IN URINE + Negative


(Method : GOD/POD)

HbA1C (Glycosylated Hemoglobin) * 6.8H 4.8-6.0 %


(Method : HPLC)

EXPECTED VALUES :-
Metabolicaly healthy patients : 4.48 -5.5 % HbAIC
Good Control : 5.5 – 6.0 % HbAIC
Fair Control : 6.0 – 7.0 % HbAIC
Poor Control : > 7.0 % HbAIC
In vitro quantitative determination of HbAIC in whole blood is utilized in long term monitoring of glycemia. The
HbAIC level correlates with the mean glucose concentration prevailing in the course of the patient's recent
history (approx - 6-8 weeks) and therefore provides much more reliable information for glycemia monitoring than do
determinations of blood glucose or urinary glucose.
It is recommended that the determination of HbAIC be performed at intervals of 6-8 weeks during Diabetes Mellitus
therapy.
Results of HbAIC should be assessed in conjunction with the patient's medical history, clinical examinations and
other findings.
ESTIMATED AVERAGE PLASMA GLUCOSE * 148.46 70-180 mg/dL

Page 5 of 13
Patient Name : Mrs.PHULWANTI KAUR
Age/Sex : 68 YRS/F Lab Id. : 012009180092
Refered By : Self Sample Collection On : 18/Sep/2020
Collected By : UMESH KAMAL Sample Lab Rec.On : 18/Sep/2020 05:55 PM
Collection Mode : HOME COLLECTION Reporting On : 18/Sep/2020 07:15 PM
BarCode : 10172896

Test Name Result Biological Ref. Int. Unit


(Method : Calculated)

Page 6 of 13
Patient Name : Mrs.PHULWANTI KAUR
Age/Sex : 68 YRS/F Lab Id. : 012009180092
Refered By : Self Sample Collection On : 18/Sep/2020
Collected By : UMESH KAMAL Sample Lab Rec.On : 18/Sep/2020 05:55 PM
Collection Mode : HOME COLLECTION Reporting On : 18/Sep/2020 07:15 PM
BarCode : 10172896

Test Name Result Biological Ref. Int. Unit

THYROID PROFILE,Serum
TRIIODOTHYRONINE - T3 0.81 0.80-2.0 ng/ml
(Method : CLIA)

THYROXINE - T4 7.42 6.09 - 12.23 ug/dl


(Method : CLIA)

THYROID STIMULATINGHORMONE - TSH 6.486H 0.35 - 5.50 uIU/mL


(Method : CLIA)

Pregnancy reference ranges for TSH


1st Trimester : 0.10 - 2.50
2nd Trimester : 0.20 - 3.00
3rd Trimester : 0.30 - 3.00
Reference: Guidelines of American Thyroid Association for the Diagnosis and Management of Thyroid Disease During Pregnancy
and Postpartum, Thyroid, 2011, 21; 1-46

COMMENTS:
The levels of Thyroid hormones (T3, T4 & FT3, FT4) are low in case of Primary, Secondary and Tertiary hypothyroidism and
sometimes in nonthyroidal illness also. Increase levels are found in Grave’s disease, Hyperthyroidism and Thyroid Hormone
resistance. TSH levels are raised in Primary Hypothyroidism and are low in Hyperthyroidism and secondary hypothyroidism.

NOTE:
TSH levels are subject to circadian variation, reaction peak levels between 2-4 am and at a minimum between 6-10 pm. The
variation is of the day has influence on the measured serum TSH concentrations.
TSH values <0.03 uIU/ml need to be clinically correlated due to presence of a rare TSH variant in some individuals.

Page 7 of 13
Patient Name : Mrs.PHULWANTI KAUR
Age/Sex : 68 YRS/F Lab Id. : 012009180092
Refered By : Self Sample Collection On : 18/Sep/2020
Collected By : UMESH KAMAL Sample Lab Rec.On : 18/Sep/2020 05:55 PM
Collection Mode : HOME COLLECTION Reporting On : 18/Sep/2020 08:19 PM
BarCode : 10172896

Test Name Result Biological Ref. Int. Unit

VITAMIN PROFILE,Serum
VITAMIN D 25 HYDROXY * 34.3 30 - 100 ng/ml
(Method : CLIA)

SERUM VITAMIN B12 * 178 75 - 807 pg/ml


(Method : CLIA)

Vitamin B12 (cobalamin) is an important water-soluble vitamin. In contrast to other water-soluble


vitamins it is not excreted quickly in the urine, but rather accumulates and is stored in the
liver, kidney and other body tissues. Humans obtain Vitamin B12 exclusively from animal dietary
sources, such as meat, eggs and milk. As a result, a vitamin B12 deficiency may not manifest itself
until after 5 or 6 years of a diet supplying inadequate amounts. Vitamin B12 functions as a methyl
donor and works with folic acid in the synthesis of DNA and red blood cells and is vitally
important in maintaining the health of the insulation sheath (myelin sheath) that surrounds nerve
cells.

Vitamin B12 is necessary for hematopoiesis and normal neuronal function. B12 deficiency may be due
to lack of intrinsic factor secretion by gastric mucosa (gastrectomy, gastric atrophy) or
intestinal malabsorption leading to Macrocytic anemia. This assay is useful for investigating
Macrocytic anemia and as a workup of deficiencies seen in Megaloblastic anemia.

Page 8 of 13
Patient Name : Mrs.PHULWANTI KAUR
Age/Sex : 68 YRS/F Lab Id. : 012009180092
Refered By : Self Sample Collection On : 18/Sep/2020
Collected By : UMESH KAMAL Sample Lab Rec.On : 18/Sep/2020 05:55 PM
Collection Mode : HOME COLLECTION Reporting On : 18/Sep/2020 07:15 PM
BarCode : 10172896

Test Name Result Biological Ref. Int. Unit

Complete Blood Count (CBC),Whole Blood EDTA


Hemoglobin (Hb) 10.3L 11.5-16.0 gm/dL
(Method : Photometric)

Red Blood Cell Count (RBC) 3L 4.5-6.5 10^6/uL


(Method : Impedance)

RBC Distribution Width (RDW-CV) 14.9 11.0-16.0 %


(Method : Calculated)

RBC Distribution Width (RDW-SD) 56.3H 35.0-56.0 FL


(Method : Calculated)

Mean Corpuscular Volume (MCV) 96.1H 76-96 fL


(Method : Calculated)

Mean Corpuscular Haemoglobin (MCH) 34H 27-33 Picogram


(Method : Calculated)

Mean Corpuscular Hb Concentration(MCHC) 35.4H 30-35 g/dL


(Method : Calculated)

Haematocrit / PCV / HCT 29.2L 40-54 %


(Method : Calculated)

Total Leucocyte Count (TLC) 1900L 4000-10000 /cumm


(Method : Flow cytometry)

DIFFERENTIAL LEUCOCYTE COUNT(DLC)


NEUTROPHIL 48.4 40-75 %
(Method : Flow cytometry)

LYMPHOCYTE 40.9H 20-40 %


(Method : Flow cytometry)

EOSINOPHIL 7.8H 1.0 - 6.0 %


(Method : Flow cytometry)

Page 9 of 13
Patient Name : Mrs.PHULWANTI KAUR
Age/Sex : 68 YRS/F Lab Id. : 012009180092
Refered By : Self Sample Collection On : 18/Sep/2020
Collected By : UMESH KAMAL Sample Lab Rec.On : 18/Sep/2020 05:55 PM
Collection Mode : HOME COLLECTION Reporting On : 18/Sep/2020 07:15 PM
BarCode : 10172896

Test Name Result Biological Ref. Int. Unit


MONOCYTE 0.9L 2.0 - 10.0 %
(Method : Flow cytometry)

BASOPHIL 2.0H 0.0 - 1.5 %


(Method : Flow cytometry)

ABSOLUTE NEUTROPHIL COUNT(ANC) 0.90L 2.0 - 7.0 10^3 / uL


(Method : Flow cytometry)

ABSOLUTE LYMPHOCYTE COUNT (ALC) 0.77L 1.0 - 3.0 10^3 / uL


(Method : Flow cytometry)

ABSOLUTE EOSINOPHIL COUNT (AEC) 0.15 0.04 - 0.44 10^3 / uL


(Method : Flow cytometry)

ABSOLUTE MONOCYTE COUNT(AMC) 0.02L 0.2 - 1.0 10^3 / uL


(Method : Flow cytometry)

ABSOLUTE BASOPHIL COUNT 0.04 0.0 - 0.100 10^3 / uL


(Method : Flow cytometry)

Platelet Count 156 150-450 10^3/ul


(Method : Impedence)

MPV 11.8 6.5 - 12 fL


(Method : Calculated)

PDW 21.2H 9.0-17.0


(Method : Calculated)

PCT 0.1L 0.108-0.208 %


(Method : Calculated)

ANEMIA STUDIES
Iron (fe) * 51.2L 55 - 150 ugm/dl
UIBC * 259 120 - 470 ug/dl
TIBC 310.20 228-428 ug/dl
(Method : Calculated)

Page 10 of 13
Patient Name : Mrs.PHULWANTI KAUR
Age/Sex : 68 YRS/F Lab Id. : 012009180092
Refered By : Self Sample Collection On : 18/Sep/2020
Collected By : UMESH KAMAL Sample Lab Rec.On : 18/Sep/2020 05:55 PM
Collection Mode : HOME COLLECTION Reporting On : 18/Sep/2020 07:15 PM
BarCode : 10172896

Test Name Result Biological Ref. Int. Unit


TRANSFERRIN SERUM * 272.11 215 - 365 mg/dl
(Method : Calculated)

% Saturation Transferrin * 16.51 16 - 50 %


(Method : Calculated)

Hemoglobin (Hb) 10.3L 11.5-16.0 gm/dL


(Method : Photometric)

Red Blood Cell Count (RBC) 3L 4.5-6.5 10^6/uL


(Method : Impedance)

Haematocrit / PCV / HCT 29.2L 40-54 %


(Method : Calculated)

Page 11 of 13
Patient Name : Mrs.PHULWANTI KAUR
Age/Sex : 68 YRS/F Lab Id. : 012009180092
Refered By : Self Sample Collection On : 18/Sep/2020
Collected By : UMESH KAMAL Sample Lab Rec.On : 18/Sep/2020 05:55 PM
Collection Mode : HOME COLLECTION Reporting On : 18/Sep/2020 07:15 PM
BarCode : 10172896

Test Name Result Biological Ref. Int. Unit

Complete Urine Examination,Urine


PHYSICAL EXAMINATION
VOLUME 25
COLOUR Pale Yellow Pale Yellow
APPEARANCE Clear
pH 5.5 5.5 - 7.0
SPECIFIC GRAVITY 1.015 1.010-1.025
Chemical Examination
GLUCOSE IN URINE + Negative
(Method : GOD/POD)

PROTEIN Negative Negative


(Method : Protein error of a ph indicator)

UROBILIOGEN Normal Negative


(Method : Ehrlic)

BILE SALT * Negative Negative


(Method : Hey,s sulphar )

BILE PIGMENT * Negative Negative


(Method : Fouchet,s )

BILIRUBIN Negative Negative


(Method : Diazo)

KETONE Negative Negative


(Method : Legal,s)

BLOOD Negative Negative


(Method : Oxidation)

NITRITE Negative Negative Negative

Page 12 of 13
Patient Name : Mrs.PHULWANTI KAUR
Age/Sex : 68 YRS/F Lab Id. : 012009180092
Refered By : Self Sample Collection On : 18/Sep/2020
Collected By : UMESH KAMAL Sample Lab Rec.On : 18/Sep/2020 05:55 PM
Collection Mode : HOME COLLECTION Reporting On : 18/Sep/2020 07:15 PM
BarCode : 10172896

Test Name Result Biological Ref. Int. Unit


(Method : Griess,s)

LEUKOCYTES Negative Negative


(Method : Granulocyte esterases&diazonium)

ASCORBIC ACID (Semi-Quantitative) Negative Negative


(Method : Tillman,s)

Microscopic Examination
PUS CELLS 2-4 0-5 /HPF
RBC Negative Negative /HPF
CASTS Negative Negative
CRYSTALS Negative Negative
EPITHELIAL CELLS 3-5 0-5 /HPF
BACTERIA Absent Absent

*** End Of Report ***

The parameter marked with * is not accredited by NABL

Page 13 of 13

You might also like